200
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Pomegranate Extract Alters Breast Cancer Stem Cell Properties in Association with Inhibition of Epithelial-to-Mesenchymal Transition

, &
Pages 1088-1098 | Received 07 Oct 2016, Accepted 06 Jul 2017, Published online: 04 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Melis Mutlu, Berrin Tunca, Secil Ak Aksoy, Cagla Tekin, Unal Egeli & Gulsah Cecener. (2021) Inhibitory Effects of Olea europaea Leaf Extract on Mesenchymal Transition Mechanism in Glioblastoma Cells. Nutrition and Cancer 73:4, pages 713-720.
Read now

Articles from other publishers (19)

Jin Cheng, Jiahui Li, Ruo-Gu Xiong, Si-Xia Wu, Si-Yu Huang, Dan-Dan Zhou, Adila Saimaiti, Ao Shang, Yibin Feng, Ren-You Gan & Hua-Bin Li. (2023) Bioactive compounds and health benefits of pomegranate: An updated narrative review. Food Bioscience 53, pages 102629.
Crossref
Alena Mazurakova, Lenka Koklesova, Desanka Vybohova, Marek Samec, Erik Kudela, Kamil Biringer, Miroslava Šudomová, Sherif T. S. Hassan, Martin Kello, Dietrich Büsselberg, Olga Golubnitschaja & Peter Kubatka. (2023) Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells. Frontiers in Pharmacology 14.
Crossref
Hanan R. H. Mohamed, Fadi S. A. Tulbah, Akmal A. El-ghor & Shaymaa M. Eissa. (2023) Suppression of tumor growth and apoptosis induction by pomegranate seed nano-emulsion in mice bearing solid Ehrlich carcinoma cells. Scientific Reports 13:1.
Crossref
Mohsen Karami Fath, Setareh Garousi, Mehran Mottahedi, Nasim Ghasemzadeh, Kiana Salmani, Fatemeh Olfati, Miad Beit Saeed, Sina Sotoudeh & Ghasem Barati. (2023) The role of hypoxia-inducible factors in breast cancer stem cell specification. Pathology - Research and Practice 243, pages 154349.
Crossref
Xiaoqiang Wang, Yin S. Chan, Kelly Wong, Ryohei Yoshitake, David Sadava, Timothy W. Synold, Paul Frankel, Przemyslaw W. Twardowski, Clayton Lau & Shiuan Chen. (2023) Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials. Cancers 15:3, pages 701.
Crossref
Panagiota D. Pantiora, Alexandros I. Balaouras, Ioanna K. Mina, Christoforos I. Freris, Athanasios C. Pappas, Georgios P. Danezis, Evangelos Zoidis & Constantinos A. Georgiou. (2023) The Therapeutic Alliance between Pomegranate and Health Emphasizing on Anticancer Properties. Antioxidants 12:1, pages 187.
Crossref
Khalid Saad Alharbi, Waleed Hassan Almalki, Hafiz A. Makeen, Mohammed Albratty, Abdulkarim M. Meraya, Rupak Nagraik, Avinash Sharma, Deepak Kumar, Dinesh Kumar Chellappan, Sachin Kumar Singh, Kamal Dua & Gaurav Gupta. (2022) Role of Medicinal plant‐derived Nutraceuticals as a potential target for the treatment of breast cancer. Journal of Food Biochemistry 46:12.
Crossref
Arunaksharan Narayanankutty. (2022) Pharmacological Potentials and Nutritional Values of Tropical and Subtropical Fruits of India: Emphasis on their Anticancer Bioactive Components. Recent Patents on Anti-Cancer Drug Discovery 17:2, pages 124-135.
Crossref
Zohre Senobari, Gholamreza Karimi & Khadijeh Jamialahmadi. (2021) Ellagitannins, promising pharmacological agents for the treatment of cancer stem cells. Phytotherapy Research 36:1, pages 231-242.
Crossref
Ammad Ahmad Farooqi. (2021) Regulation of deregulated cell signaling pathways by pomegranate in different cancers: Re-interpretation of knowledge gaps. Seminars in Cancer Biology 73, pages 294-301.
Crossref
Tin Lok Wong, Kayla R. Strandberg, Courtney R. Croley, Sarah E. Fraser, Kalyan C. Nagulapalli Venkata, Carmela Fimognari, Gautam Sethi & Anupam Bishayee. (2021) Pomegranate bioactive constituents target multiple oncogenic and oncosuppressive signaling for cancer prevention and intervention. Seminars in Cancer Biology 73, pages 265-293.
Crossref
Sheng-Yao Peng, Li-Ching Lin, Shu-Rong Chen, Ammad A. Farooqi, Yuan-Bin Cheng, Jen-Yang Tang & Hsueh-Wei Chang. (2021) Pomegranate Extract (POMx) Induces Mitochondrial Dysfunction and Apoptosis of Oral Cancer Cells. Antioxidants 10:7, pages 1117.
Crossref
Jiejie Cui, Mengjia Gong, Shuyu Fang, Chaoqun Hu, Yi Wang, Jingfang Zhang, Ni Tang & Yun He. (2021) All-trans retinoic acid reverses malignant biological behavior of hepatocarcinoma cells by regulating miR-200 family members. Genes & Diseases 8:4, pages 509-520.
Crossref
Marius Alexandru Moga, Oana Gabriela Dimienescu, Andreea Bălan, Lorena Dima, Sebastian Ionut Toma, Nicușor Florin Bîgiu & Alexandru Blidaru. (2021) Pharmacological and Therapeutic Properties of Punica granatum Phytochemicals: Possible Roles in Breast Cancer. Molecules 26:4, pages 1054.
Crossref
Sheng‐Yao Peng, Chien‐Chou Hsiao, Ting‐Hsun Lan, Ching‐Yui Yen, Ammad A. Farooqi, Chih‐Mei Cheng, Jen‐Yang Tang, Tzu‐Jung Yu, Yun‐Chiao Yeh, Ya‐Ting Chuang, Chien‐Chih Chiu & Hsueh‐Wei Chang. (2020) Pomegranate extract inhibits migration and invasion of oral cancer cells by downregulating matrix metalloproteinase‐2/9 and epithelial‐mesenchymal transition. Environmental Toxicology 35:6, pages 673-682.
Crossref
Sawsan G. Mohammed & M. Walid Qoronfleh. 2020. Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management. Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management 279 376 .
Xiaofei Ning, Cong Wang, Meng Zhang & Kecheng Wang. (2019) Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial‐Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27:4, pages 399-406.
Crossref
Lisha Xiang & Gregg L. Semenza. 2019. Cancer Stem Cells. Cancer Stem Cells 175 212 .
Pilar Carranza-Rosales, Nancy Elena Guzmán-Delgado, Irma Edith Carranza-Torres, Ezequiel Viveros-Valdez & Javier Morán-Martínez. 2021. Three Dimensional Human Organotypic Models for Biomedical Research. Three Dimensional Human Organotypic Models for Biomedical Research 199 223 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.